Stock screener

SRPT

Conviction 45HealthcareScan · Thu, Sep 24, 2026

Sarepta Therapeutics, Inc. (SRPT) closed at $18.38 (-3.01%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 42, RS Rating 77, -24.8% from its 52-week high, -13.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

SRPT$18.38-3.01%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 3.26M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Sarepta Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.sarepta.com ↗
Price18.38
Change-3.01%
Gap-0.55%
Rel volume1.29×
Avg volume3.5M
Avg $ vol73.27M
SMA 2020.90
SMA 5018.65
SMA 20019.22
Price vs 50-1.45%
Price vs 200-4.39%
MA stackbearish
50/200 cross—
Supertrenddown · 22.60
RSI (14)42
MACD hist-0.40
MACD crossbear · 9d
Stoch %K / %D6 / 14
ADX (14)25
+DI / −DI25 / 26
RSI divergence—
MACD divergence—
ATR %7.19%
ADR %6.95%
52w high24.45
52w low14.86
From 52w high-24.83%
Above 52w low+23.69%
New 52w highNo
SqueezeOff
Bollinger width22.36%
%B-0.04
Donchian pos5.92%
Donchian high23.62
Donchian low18.05
AVWAP (52w high)19.58
vs AVWAP high-6.11%
AVWAP (52w low)18.29
vs AVWAP low+0.48%
OBV trendFlat
Chaikin MF (20)0.02
Today vs 20d1.29×
Avg vol (14d)3.26M
Avg vol (20d)3.5M
Avg $ vol (20d)73.27M
Market cap1.94B
RS Rating77 / 99
RS 3m (vs SPY)+10.24%
RS 6m (vs SPY)-39.49%
RS line new highNo
Trend template3/8
Technical rank32.4
1 week-11.08%
1 month-2.85%
3 months+14.73%
6 months-22.68%
1 year+2.51%
YTD-13.75%
P/E-2.72
P/B1.27
P/S1.04
P/FCF-6.31
EPS-7.13
Div yield—
ROE-46.70%
ROA-22.37%
Debt/Eq0.00
Current4.42
EV/EBITDA-2.09
Gross margin-1.56%
Net margin-38.27%
Rev growth4.27%
EPS growth-403.27%
Price target22.29
Target upside21.27%
Analyst ratingHold
Institutional115.22%
Ent. value1.37B
Revenue328.69M
Net income-4.89M
Gross profit—
Free cash flow-307.45M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out105.58M
Employees835
ListedWed, Jun 4, 1997
Free float96.61M
Float %92.2%
Short interest24.62M
Days to cover8.5d
Short volume68.7%
Squeeze score88 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.42 vs $0.34
Last surprise+23.5% beat
Setup gradeC
Conviction45 / 100
Pattern quality—
Tech rank32.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance23.42
Support16.22
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 26
    1 scan
  2. Breaking out now
    Aug 27
    1 scan

Congress activity

Disclosed STOCK Act trades in SRPT · 1 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-04-14
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in SRPT

InsiderSideShares
BEHRENS M KATHLEEN
Director · Common Stock · 2026-06-04
Grant16.88K
Connelly Deirdre P
Director · Common Stock · 2026-06-04
Grant16.88K
Wigzell Hans Lennart Rudolf
Director · Common Stock · 2026-06-04
Grant16.88K
Barry Richard
Director · Common Stock · 2026-06-04
Other—
Nicaise Claude
Director · Common Stock · 2026-06-04
Grant16.88K
Barry Richard
Director · Common Stock · 2026-06-04
Grant16.88K
Mayo Stephen
Director · Common Stock · 2026-06-04
Grant16.88K
BEHRENS M KATHLEEN
Director · Common Stock · 2026-06-04
Other—
Chambers Michael Andrew
Director · Common Stock · 2026-06-04
Other—
Chambers Michael Andrew
Director · Common Stock · 2026-06-04
Grant16.88K

SEC filings

EDGAR filings in SRPT · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.